A retrospective, single cenre study analysing Cemiplimab as upfront intervention in locally advanced cutaneous squamous cell carcinoma
Latest Information Update: 19 Jun 2020
At a glance
- Drugs Cemiplimab (Primary)
- Indications Skin cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 19 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology